Verastem (VSTM) Current Assets (2011 - 2026)
Verastem's (VSTM) quarterly Current Assets came in at $202.9 million in Q1 2026, up 62.72% year-on-year from $124.7 million in Q1 2025, and down 9.18% quarter-over-quarter from $223.4 million in Q4 2025.
Verastem (VSTM) Current Assets (2011 - 2026) Analysis & Trends
Verastem's Current Assets history runs 16 years deep, the most recent figure standing at $202.9 million for Q1 2026.
- On a quarterly basis, Current Assets rose 62.72% year-over-year to $202.9 million in Q1 2026; TTM through Mar 2026 was $202.9 million, a 62.72% increase from a year earlier, with the FY2025 full-year figure at $223.4 million, up 135.27% from the prior year.
- Current Assets slipped to $202.9 million in Q1 2026 per VSTM's latest filing, from $223.4 million in the prior quarter.
- Across five years, Current Assets topped out at $223.4 million in Q4 2025 and bottomed at $92.9 million in Q4 2022.
- The 5-year median for Current Assets is $120.7 million (2024), against an average of $138.4 million.
- Across the five-year window, Current Assets plunged 47.54% in 2024 and soared 135.27% in 2025, its largest moves.
- Year by year, Current Assets stood at $92.9 million in 2022, then soared by 54.71% to $143.7 million in 2023, then tumbled by 33.91% to $95.0 million in 2024, then surged by 135.27% to $223.4 million in 2025, then dropped by 9.18% to $202.9 million in 2026.
- Per Business Quant, the three latest VSTM Current Assets figures stand at $202.9 million (Q1 2026), $223.4 million (Q4 2025), and $154.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | 202.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202.90 Mn |
| Dec 31, 2025 | 223.41 Mn |
| Sep 30, 2025 | 154.06 Mn |
| Jun 30, 2025 | 174.27 Mn |
| Mar 31, 2025 | 124.70 Mn |
| Dec 31, 2024 | 94.96 Mn |
| Sep 30, 2024 | 120.66 Mn |
| Jun 30, 2024 | 99.65 Mn |
| Mar 31, 2024 | 117.67 Mn |
| Dec 31, 2023 | 143.68 Mn |
| Sep 30, 2023 | 174.49 Mn |
| Jun 30, 2023 | 189.96 Mn |
| Mar 31, 2023 | 118.89 Mn |
| Dec 31, 2022 | 92.87 Mn |
| Sep 30, 2022 | 108.76 Mn |
| Jun 30, 2022 | 97.88 Mn |
| Mar 31, 2022 | 113.44 Mn |
| Dec 31, 2021 | 105.74 Mn |
| Sep 30, 2021 | 108.76 Mn |
| Jun 30, 2021 | 114.76 Mn |